PSX Company Profiles
What listed companies do, how they make money, key financials and Shariah status, researched by the PSX Investors Zone team.
10 companies
Glass & Ceramics
Ghani Value Glass Limited
Ghani Value Glass Limited (PSX: GVGL) is a Pakistani glass manufacturer incorporated in 1967 and headquartered in Lahore. The company manufactures and trades a range of glass products, including mirrors, tempered glass, laminated glass, bullet-resistant glass, printed and painted glass, and appliance glass. It operates within the Glass & Ceramics sector and is associated with the wider Ghani Group. For FY2026, the company reported net revenue of approximately Rs6.972 billion, up from Rs6.062 billion in FY2025. Profit after tax declined to Rs985.59 million from Rs1.085 billion, while earnings per share decreased from Rs7.23 to Rs6.57. The company attributed the decline in net profit to a higher income-tax burden despite improved revenue and gross profit. GVGL was classified as Shariah-compliant in the PSX KMI All Share screening published on May 29, 2026, based on financial statements through December 2025. The screening reported debt, non-compliant investment, and non-compliant income ratios of 0.00%. These ratios belong to that specific review period and should not be presented as FY2026 screening results. For FY2026, the board recommended a final cash dividend of Rs1.00 per share in addition to a 10% interim dividend already paid. The final dividend was scheduled for shareholder consideration at the October 28, 2026 AGM; its approval and payment must be verified through subsequent official announcements. Sources: [PSX company profile](https://dps.psx.com.pk/company/GVGL) | [Company investor relations](https://ghanivalueglass.com/investor-relations/) | [PSX KMI screening](https://dps.psx.com.pk/download/attachment/277899-1.pdf)
Cement
Gharibwal Cement Limited
Gharibwal Cement Limited (PSX: GWLC) is a Pakistani cement manufacturer incorporated on December 29, 1960. The company is engaged in the production and sale of cement and operates in Pakistan's cement industry, where demand is influenced by construction activity, infrastructure spending, energy prices, freight costs, and competition. For FY2026, GWLC reported net sales of approximately Rs22.313 billion, compared with Rs19.687 billion in FY2025. Profit after tax increased to Rs2.345 billion from Rs2.205 billion, while earnings per share rose to Rs5.86 from Rs5.51. However, the quarter ended September 30, 2026, showed a significant deterioration. Net sales fell to approximately Rs3.852 billion from Rs4.928 billion in the corresponding quarter of the previous year, while profit after tax declined to Rs9.07 million from Rs277.58 million. Investors should investigate the causes of this quarterly decline before drawing conclusions about future earnings. GWLC was classified as Shariah-compliant in the PSX KMI All Share screening published in May 2026, based on financial statements through December 2025. The company also has a material PSX Risk Warning Alert concerning possible suspension of trading or delisting. This regulatory issue should be reviewed independently of its financial performance and Shariah status. Sources: [Official PSX profile](https://dps.psx.com.pk/company/GWLC) | [Official KMI screening](https://www.psx.com.pk/psx/themes/psx/uploads/PSX-N-610-KMI30-re-compostion-Dec25.pdf) | [Q1 FY2027 results](https://www.investify.pk/announcements/GWLC/dps-pdf-286774)
Pharmaceuticals
GlaxoSmithKline Pakistan Limited
GlaxoSmithKline Pakistan Limited (PSX: GLAXO) is a pharmaceutical company engaged in manufacturing and marketing research-based medicines and other pharmaceutical products in Pakistan. It is part of the global GSK group and operates across therapy areas including anti-infectives, dermatology, analgesics, and vaccines. For the year ended December 31, 2025, the company reported sales of approximately Rs65.90 billion, profit after tax of Rs10.03 billion, and earnings per share of Rs31.48. Its financial performance, product portfolio, manufacturing operations, regulatory environment, and cash-flow position are important factors for fundamental analysis. GLAXO was classified as Shariah-compliant in the PSX KMI All Share screening published in May 2026, based on financial statements available through December 2025. Investors should check subsequent screening updates before making decisions. **Important:** The official PSX company page displays a Risk Warning Alert stating that the company is in continuous violation of specified exchange clauses and carries a risk of trading suspension or delisting. Investors should review the latest PSX disclosures and understand this regulatory risk before evaluating the stock. Sources: [PSX company profile and financials](https://dps.psx.com.pk/company/GLAXO) | [GSK Pakistan](https://pk.gsk.com/en-pk/company/) | [PSX KMI screening notice](https://www.psx.com.pk/psx/files/?file=277899-1.pdf)
Sports Goods Manufacturing
GOC (Pakistan) Limited
GOC (Pakistan) Limited (PSX: GOC) is a Pakistani sports goods manufacturer based in Sialkot. Incorporated in 1964, the company manufactures and sells cricket balls, hockey balls, and other sporting goods. Its business includes supplying products under its own brand and manufacturing for other brands. For the financial year ended June 30, 2026, GOC reported revenue of approximately Rs508.78 million, profit after tax of Rs52.47 million, and earnings per share of Rs7.14. Compared with FY2025, revenue increased from Rs472.32 million and profit after tax rose from Rs25.83 million. However, operating cash flow was negative in FY2026, making cash conversion an important area for investors to examine. GOC was classified as Shariah-compliant in the PSX KMI All Share screening published in May 2026, based on December 2025 financial statements. Its reported non-compliant income ratio was 0.23%. **Important regulatory risk:** The official PSX profile displays a Risk Warning Alert concerning continuous violation of specified exchange clauses and the risk of trading suspension or delisting. This alert is material and should be reviewed alongside the company's financial performance and Shariah status. Sources: [PSX profile and financials](https://dps.psx.com.pk/company/GOC) | [FY2026 financial statements](https://dps.psx.com.pk/download/document/282979.pdf) | [Official Shariah screening](https://dps.psx.com.pk/download/attachment/277899-1.pdf)
Textile Composite (PSX classification); Rental Income from Investment Properties
Hafiz Limited
Hafiz Limited (PSX: HAFL) is a Pakistan Stock Exchange-listed company incorporated in 1951. According to the official PSX company profile, its principal activity is earning rental income from investment properties. For FY2026, the company reported rental income of Rs43.16 million, profit after tax of Rs58.45 million and earnings per share of Rs48.71, compared with Rs39.29 million, Rs52.89 million and Rs44.08, respectively, in FY2025. The final cash dividend of Rs3.00 per share for FY2026 was approved at the company's October 22, 2026 AGM. Hafiz Limited was classified as Shariah-compliant in the PSX-KMI All Share Islamic Index recomposition published in May 2026, based on December 2025 financial statements. However, PSX also displays a Risk Warning Alert concerning continuous exchange-rule violations and potential suspension or delisting. Investors should review the latest official disclosures and Shariah screening before making decisions.
Pharmaceuticals
Haleon Pakistan Limited
Haleon Pakistan Limited (PSX: HALEON) is a listed consumer healthcare company manufacturing, marketing and selling over-the-counter health products in Pakistan. Formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, it became part of the independent Haleon group following the consumer healthcare demerger. Its product portfolio includes well-known brands in pain relief, oral health, respiratory health and vitamins and supplements. For 2025, the company reported revenue of Rs43.106 billion, profit after tax of Rs6.373 billion and EPS of Rs54.45. Its latest reviewed 2026 quarterly results, for the quarter ended June 30, reported revenue of Rs10.072 billion and profit after tax of Rs1.676 billion. Haleon Pakistan was classified as Shariah-compliant in the PSX-KMI All Share Islamic Index recomposition published in May 2026, based on December 2025 financial statements. However, the official PSX profile displays a Risk Warning Alert concerning continuous exchange-rule violations and potential trading suspension or delisting. Investors should verify the latest exchange notices and Shariah screening before making decisions.
Automobile Assembler
Hinopak Motors Limited
Hinopak Motors Limited (PSX: HINO) is a Pakistan Stock Exchange-listed commercial vehicle assembler and manufacturer specializing in Hino trucks, buses, spare parts and accessories. The company is a subsidiary of Hino Motors Limited of Japan, with Toyota Motor Corporation as its ultimate parent. For the financial year ended March 31, 2026, Hinopak reported sales of Rs11.001 billion, profit after tax of Rs541.253 million and EPS of Rs21.82, compared with sales of Rs10.337 billion, profit after tax of Rs161.957 million and EPS of Rs6.53 in FY2025. It was classified as Shariah-compliant in the PSX-KMI All Share Islamic Index recomposition published in May 2026, based on December 2025 financial statements. However, the official PSX company page displays a Risk Warning Alert concerning continuous exchange-rule violations and potential suspension or delisting. Investors should review the latest financial statements, Shariah screening and exchange notices before making investment decisions.
Pharmaceuticals
Hoechst Pakistan Limited
Hoechst Pakistan Limited (PSX: HPL) is a Pakistan Stock Exchange-listed pharmaceutical company engaged in manufacturing, selling and trading pharmaceutical and related products. Incorporated in 1967, the company operates from Korangi Industrial Area, Karachi, and reports its financial results on a calendar-year basis. In FY2025, Hoechst Pakistan reported sales of Rs30.929 billion, profit after tax of Rs2.910 billion and EPS of Rs301.67, compared with sales of Rs26.748 billion and profit after tax of Rs1.857 billion in FY2024. For the quarter ended September 30, 2026, it reported sales of Rs7.790 billion, profit after tax of Rs614.346 million and EPS of Rs63.70. HPL was classified as Shariah-compliant in the PSX-KMI All Share Islamic Index recomposition published in May 2026, based on December 2025 financial statements. Investors should monitor quarterly profitability, product and regulatory developments, dividend sustainability and any changes in the company's latest Shariah screening status.
Automobile Assembler
Honda Atlas Cars (Pakistan) Limited
Honda Atlas Cars (Pakistan) Limited (PSX: HCAR) is a listed automobile assembler and a joint venture between Honda Motor Co., Japan, and Pakistan’s Atlas Group. The company assembles and progressively manufactures Honda vehicles and sells vehicles and spare parts in Pakistan. For the financial year ended March 31, 2026, it reported sales of Rs122.283 billion, profit after tax of Rs3.234 billion and EPS of Rs22.64, compared with sales of Rs78.066 billion and profit after tax of Rs2.709 billion in FY2025. A dividend of Rs9 per share was declared for FY2026. HCAR was classified as Shariah-compliant in the PSX-KMI All Share Islamic Index recomposition published in May 2026 and was included in the KMI-30 recomposition. However, the official PSX company page displays a Risk Warning Alert concerning exchange-rule violations and potential suspension or delisting. Investors should review the latest financial statements, Shariah screening and PSX notices before making investment decisions.
Pharmaceuticals
IBL HealthCare Limited
IBL HealthCare Limited (PSX: IBLHL) is a Pakistani healthcare-products distribution and marketing company incorporated in 1997 and listed on the Pakistan Stock Exchange. Its principal activities include marketing, selling and distributing healthcare and pharmaceutical products across categories including nutrition, sweeteners and beverages, and medical and surgical disposables. The company is a subsidiary of The Searle Company Limited. In FY2026, IBL HealthCare reported revenue of Rs4.607 billion, profit after tax of Rs220.402 million and EPS of Rs2.24, compared with revenue of Rs4.322 billion and profit after tax of Rs208.371 million in FY2025. The board declared no cash dividend for FY2026. IBLHL was classified as Shariah-compliant in the PSX-KMI All Share Islamic Index recomposition published in May 2026, based on December 2025 financial data. Investors should also note that PSX currently displays a Risk Warning Alert concerning potential trading suspension or delisting, making the latest exchange notices essential reading.